Market Cap 133.03M
Revenue (ttm) 0.00
Net Income (ttm) -36.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.91
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 646,615
Avg Vol 420,274
Day's Range N/A - N/A
Shares Out 21.49M
Stochastic %K 62%
Beta 1.85
Analysts Strong Sell
Price Target $44.14

Company Profile

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also evaluates licensing of technologies and drugs for orphan diseases, other renal, li...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 351 4495
Address:
4300 El Camino Real, Suite 210, Los Altos, United States
anan1
anan1 Jan. 20 at 5:17 PM
$UNCY why in options it is showing maximum 10 for August. It means after approval it will not go above 10.00?
0 · Reply
JDubbs530
JDubbs530 Jan. 20 at 5:15 PM
$UNCY when we hit 8 I can finally exit this garbage
0 · Reply
Eagley3k
Eagley3k Jan. 20 at 3:49 PM
$UNCY whale continues........... breaking out of 3 years downtrend line. imminent reversal. $XBI $IBB $IWM
0 · Reply
ppl_first
ppl_first Jan. 20 at 3:29 PM
$UNCY Today's run based on what?
0 · Reply
Eagley3k
Eagley3k Jan. 20 at 2:45 PM
$UNCY Looks like a big volume day. Breakout is in play. If confirmed, could see $8S
0 · Reply
Jumpingfox
Jumpingfox Jan. 17 at 8:00 PM
$UNCY Informative interview with the founder of UNCY regarding the details of the groundbreaking drug, oxylanthanum carbonate (OLC), marketing strategy and potential market share. “Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC” from Stocks Down Under. https://youtu.be/c0xAx4Ol9dY
1 · Reply
Eagley3k
Eagley3k Jan. 16 at 2:42 PM
$OSTX not expecting anything long as $XBI is in the red $UNCY
0 · Reply
KirkHanna
KirkHanna Jan. 15 at 11:59 PM
$UNCY Well summarized https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-uncy/unicycive-therapeutics/6fukzgel-update-for-unicycive-therapeutics
0 · Reply
zawojak
zawojak Jan. 15 at 2:39 PM
$UNCY ouch some hedges dumping seems like it.
0 · Reply
zawojak
zawojak Jan. 15 at 1:11 PM
$UNCY it seems like FOMO just started folks !!! Why?.we may get good news about Re-submission to FDA any time now by end of Jan. Potential 10-40% run.
0 · Reply
Latest News on UNCY
Unicycive Therapeutics, Inc. Announces Reverse Stock Split

Jun 17, 2025, 7:00 AM EDT - 7 months ago

Unicycive Therapeutics, Inc. Announces Reverse Stock Split


anan1
anan1 Jan. 20 at 5:17 PM
$UNCY why in options it is showing maximum 10 for August. It means after approval it will not go above 10.00?
0 · Reply
JDubbs530
JDubbs530 Jan. 20 at 5:15 PM
$UNCY when we hit 8 I can finally exit this garbage
0 · Reply
Eagley3k
Eagley3k Jan. 20 at 3:49 PM
$UNCY whale continues........... breaking out of 3 years downtrend line. imminent reversal. $XBI $IBB $IWM
0 · Reply
ppl_first
ppl_first Jan. 20 at 3:29 PM
$UNCY Today's run based on what?
0 · Reply
Eagley3k
Eagley3k Jan. 20 at 2:45 PM
$UNCY Looks like a big volume day. Breakout is in play. If confirmed, could see $8S
0 · Reply
Jumpingfox
Jumpingfox Jan. 17 at 8:00 PM
$UNCY Informative interview with the founder of UNCY regarding the details of the groundbreaking drug, oxylanthanum carbonate (OLC), marketing strategy and potential market share. “Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC” from Stocks Down Under. https://youtu.be/c0xAx4Ol9dY
1 · Reply
Eagley3k
Eagley3k Jan. 16 at 2:42 PM
$OSTX not expecting anything long as $XBI is in the red $UNCY
0 · Reply
KirkHanna
KirkHanna Jan. 15 at 11:59 PM
$UNCY Well summarized https://simplywall.st/community/narratives/us/pharmaceuticals-biotech/nasdaq-uncy/unicycive-therapeutics/6fukzgel-update-for-unicycive-therapeutics
0 · Reply
zawojak
zawojak Jan. 15 at 2:39 PM
$UNCY ouch some hedges dumping seems like it.
0 · Reply
zawojak
zawojak Jan. 15 at 1:11 PM
$UNCY it seems like FOMO just started folks !!! Why?.we may get good news about Re-submission to FDA any time now by end of Jan. Potential 10-40% run.
0 · Reply
BinaryLogic
BinaryLogic Jan. 15 at 6:23 AM
0 · Reply
Legendary_Scoober
Legendary_Scoober Jan. 14 at 9:18 PM
$UNCY 15% drop tomorrow?
2 · Reply
Eagley3k
Eagley3k Jan. 14 at 8:02 PM
$UNCY feels like a whale is loading. we need to break out of that 3 years down slope line and we are in full reversal mode. $XBI $IBB $IWM
1 · Reply
psight
psight Jan. 14 at 6:31 PM
$UNCY $8 once the resubmission is accepted by the FDA and then they will issue a PDUFA date, usually 6 months from the day of acceptance. So July '26 will be the PDUFA date, in my expectations. In my opinion, the stock should be trading between $8-10 by the day of acceptance and $16-20 just prior to PDUFA date. The PDUFA run might start in late June. Gentlemen, place your bets :-)
3 · Reply
zawojak
zawojak Jan. 14 at 5:46 PM
$UNCY is something finally cooking?
2 · Reply
Eagley3k
Eagley3k Jan. 14 at 3:32 PM
$UNCY a test of $7 might be in the cards
1 · Reply
11thestate
11thestate Jan. 14 at 2:37 PM
$UNCY investors — the loss speaks for itself. Here’s an update worth your attention: a few days ago, a case was filed against Unicycive Therapeutics. We’re tracking it closely so you don’t miss your chance to recover losses. Be sure to check in — we’ll keep you updated: https://11th.com/cases/unicycive-investor-suit
0 · Reply
HamBoneXoXo
HamBoneXoXo Jan. 14 at 6:30 AM
$UNCY They resubmitted on 29 Dec. I expect fda acceptance by 29 Jan.
1 · Reply
Connercook12
Connercook12 Jan. 12 at 5:06 PM
$UNCY does anyone know why this isn’t up more yet? They have enough cash to go to 2027 and it seems like they will have there drug approved in the next year. What am I missing?
3 · Reply
psight
psight Jan. 11 at 10:33 PM
$UNCY Here is how UNCY will play out and why. The application needs to be accepted in the first place, That should happen in less than a month. But there is NO guarantee it will be accepted by the FDA. If accepted, there will be an ascend in the price in the expectation of approval - closer to the PDUFA date. But in the interim, there will be price fluctuations - MM manipulations, short attacks etc. (referring to the 6-month waiting period) If approved, there will be a temporary spike. But lately, the FDA approvals are met with huge selling. Given all these scenarios, I would not expect the price to go high till we approach PDUFA date. After that, it's anybody's guess. That said, I am going to hold for now, buy more after the application is accepted and wait till close to PDUFA date. I expect by that time, the stock will be trading in the $15-18 range. All this, IMHO.
3 · Reply
zawojak
zawojak Jan. 10 at 1:45 PM
$AQST similar situation as $UNCY also had labeling issue. Now waiting over 6 months for re submisssion.
0 · Reply
RunningRobert1
RunningRobert1 Jan. 9 at 3:29 PM
$UNCY This stock wants to move up, and at some point it will jump, everyday we see the same thing up to 6.30+ and then drop back to 6
2 · Reply